Guardian Pharmacy Services (NYSE:GRDN) Trading Down 5% – What’s Next?

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) fell 5% during trading on Thursday . The stock traded as low as $19.23 and last traded at $19.24. 140,536 shares changed hands during trading, a decline of 26% from the average session volume of 189,088 shares. The stock had previously closed at $20.26.

Analyst Ratings Changes

A number of analysts have recently weighed in on GRDN shares. Raymond James assumed coverage on shares of Guardian Pharmacy Services in a research note on Monday, October 21st. They issued an “outperform” rating and a $21.00 price objective for the company. Truist Financial boosted their target price on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, November 15th. Finally, Stephens initiated coverage on shares of Guardian Pharmacy Services in a report on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 price target for the company.

Guardian Pharmacy Services Stock Performance

The stock has a 50-day simple moving average of $21.93.

Guardian Pharmacy Services (NYSE:GRDN) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The firm had revenue of $314.39 million for the quarter, compared to analyst estimates of $303.21 million. Equities analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Insider Buying and Selling at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Steven D. Cosler purchased 7,000 shares of the stock in a transaction on Tuesday, November 19th. The shares were purchased at an average price of $21.22 per share, with a total value of $148,540.00. Following the acquisition, the director now directly owns 17,713 shares of the company’s stock, valued at $375,869.86. This represents a 65.34 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Hedge Funds Weigh In On Guardian Pharmacy Services

Hedge funds and other institutional investors have recently made changes to their positions in the business. Stephens Inc. AR acquired a new stake in Guardian Pharmacy Services in the 3rd quarter valued at $189,000. Virtu Financial LLC bought a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth about $279,000. Barclays PLC acquired a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth about $311,000. Point72 DIFC Ltd acquired a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth about $573,000. Finally, Royce & Associates LP bought a new position in Guardian Pharmacy Services during the 3rd quarter valued at about $1,260,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.